ARTAÇ, M. Et Al. 2014. Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. TUMORI JOURNAL , vol.100, no.2 , 143-148.

ARTAÇ, M., Turha, N. S., Kocer, M., KARABULUT, B., Bozcuk, H., YALÇIN, S. S., ... KARAAĞAÇ, M.(2014). Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study. TUMORI JOURNAL , vol.100, no.2, 143-148.

ARTAÇ, MEHMET Et Al. "Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study," TUMORI JOURNAL , vol.100, no.2, 143-148, 2014

ARTAÇ, MEHMET Et Al. "Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study." TUMORI JOURNAL , vol.100, no.2, pp.143-148, 2014

ARTAÇ, M. Et Al. (2014) . "Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study." TUMORI JOURNAL , vol.100, no.2, pp.143-148.

@article{article, author={MEHMET ARTAÇ Et Al. }, title={Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study}, journal={TUMORI JOURNAL}, year=2014, pages={143-148} }